2020
DOI: 10.1002/bmc.4847
|View full text |Cite
|
Sign up to set email alerts
|

Metabolomics approach based on utra‐performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high‐throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction

Abstract: Ultra‐performance liquid chromatography/mass spectrometry‐based metabolomics can been used for discovery of metabolite biomarkers to explore the metabolic pathway of diseases. Identification of metabolic pathways is key to understanding the pathogenesis and mechanism of disease. Myocardial dysfunction induced by sepsis (SMD) is a severe complication of septic shock and represents major causes of death in intensive care units; however its pathological mechanism is still not clear. In this study, ultrahigh‐press… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 36 publications
0
4
0
Order By: Relevance
“…Metabolomics as an instantly emerging “omics” device points to qualitative and quantitative analysis of endogenic small metabolites in cells, tissues, organs or biological fluids, and help understand the metabolomic profiling changes indicating the details of the underlying pathways in response to endogenous and exogenous impetus, such as food, drug, and pathogen ( Sakaguchi et al, 2019 ; Xie et al, 2019 ; Xiong et al, 2019 ). Recently, modern high-throughput technology including nuclear magnetic resonance spectroscopy (NMR), gas chromatography mass spectrometry (GC-MS), liquid chromatography mass spectrometry (LC-MS), or capillary electro-phoresis mass spectrometry (CE-MS) coupled with multivariate analysis was successfully performed multiparametric metabolic responses to pathophysiological and environmental perturbations in metabolomics research ( Sun et al, 2013b ; Zhang et al, 2017 ; Sun et al, 2019 ; Zhao et al, 2020 ). It has been widely used in early diagnosis, disease staging, and treatment evaluation of osteoporosis ( Lv et al, 2016 ; Zhao et al, 2018 ; Xia et al, 2019 ; Zhang et al, 2019 ; Ye et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Metabolomics as an instantly emerging “omics” device points to qualitative and quantitative analysis of endogenic small metabolites in cells, tissues, organs or biological fluids, and help understand the metabolomic profiling changes indicating the details of the underlying pathways in response to endogenous and exogenous impetus, such as food, drug, and pathogen ( Sakaguchi et al, 2019 ; Xie et al, 2019 ; Xiong et al, 2019 ). Recently, modern high-throughput technology including nuclear magnetic resonance spectroscopy (NMR), gas chromatography mass spectrometry (GC-MS), liquid chromatography mass spectrometry (LC-MS), or capillary electro-phoresis mass spectrometry (CE-MS) coupled with multivariate analysis was successfully performed multiparametric metabolic responses to pathophysiological and environmental perturbations in metabolomics research ( Sun et al, 2013b ; Zhang et al, 2017 ; Sun et al, 2019 ; Zhao et al, 2020 ). It has been widely used in early diagnosis, disease staging, and treatment evaluation of osteoporosis ( Lv et al, 2016 ; Zhao et al, 2018 ; Xia et al, 2019 ; Zhang et al, 2019 ; Ye et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, they can be non-invasive for the patients if carried out on urine or saliva, which should be greatly encouraged, and the use of chemometric tools becomes crucial to evaluate the contemporary effect of several metabolites. In this sense, Zhao et al [116] used PCA and OPLS-DA in a preliminary search for metabolite biomarkers to explore the abnormal urinary metabolic pathways associated with myocardial dysfunction. Similarly, Yao et al [117] used PCA and PLS-DA on HPLC-MS data to investigate the effect of an hepatoprotective treatment in liver-injured rats, finding differences in metabolic pathways of plasma and urine.…”
Section: High-performance Liquid Chromatography (Hplc) and Chemometricsmentioning
confidence: 99%
“…Gas chromatography-mass spectrometry (GC-MS), liquid chromatography or capillary electrophoresis coupled with MS (LC-MS/CE-MS), and nuclear magnetic resonance (NMR) are tools for high-throughput screening of biomarkers and metabolite pro ling that are increasingly being applied to medical diagnostics [7][8][9]. Metabolomic analysis using these methods allows evaluation of changes in the relative abundance of low molecular weight metabolites such as amino acids (AAs), fatty acids (FAs), amines, organic acids, and nucleosides in physiologic and pathologic contexts.…”
Section: Introductionmentioning
confidence: 99%